MARKET

OTLKW

Outlook Therapeutics Inc
OTLKW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.2941
0.0670
1.149
-
BUZZ-Outlook Therapeutics slides after US FDA declines its eye disease drug
Reuters · 12/31/2025 22:21
OUTLOOK THERAPEUTICS INC: FDA HAS NOT INDICATED WHAT TYPE OF CONFIRMATORY EVIDENCE WOULD BE ACCEPTABLE
Reuters · 12/31/2025 21:15
Outlook Therapeutics Grants Stock Options to New Employees
Reuters · 12/26/2025 22:00
OUTLOOK THERAPEUTICS REPORTS FINANCIAL RESULTS FOR FISCAL YEAR 2025
Reuters · 12/19/2025 13:05
FDA Sets December 31 PDUFA Date for Outlook Therapeutics’ ONS-5010 BLA Review
Reuters · 11/13/2025 21:17
OUTLOOK THERAPEUTICS INC: ONS-5010, IF APPROVED, WILL BE BRANDED AS LYTENAVA FOR TREATMENT OF WET AMD
Reuters · 11/13/2025 13:30
OUTLOOK THERAPEUTICS RE-SUBMITS BIOLOGICS LICENSE APPLICATION FOR ONS-5010
Reuters · 11/03/2025 13:35
OUTLOOK THERAPEUTICS INC - IF APPROVED, ONS-5010 TO BE BRANDED AS LYTENAVA FOR WET AMD
Reuters · 11/03/2025 13:35
More

Webull offers Outlook Therapeutics Inc stock information, including NASDAQ: OTLKW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OTLKW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OTLKW stock methods without spending real money on the virtual paper trading platform.